Voyager Therapeutics (VYGR) Operating Leases (2019 - 2026)
Voyager Therapeutics (VYGR) posted Operating Leases of $27.2 million for Q1 2026, down 5.08% sequentially from $28.7 million in Q4 2025, and down 21.3% YoY from $34.6 million in Q1 2025.
Voyager Therapeutics (VYGR) Operating Leases (2019 - 2026) Analysis & Trends
Voyager Therapeutics has reported Operating Leases for 8 years, with the latest figure at $27.2 million in Q1 2026.
- Quarterly Operating Leases fell 21.3% year-over-year to $27.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.2 million (down 21.3% YoY) and the FY2025 annual result came in at $28.7 million, down 21.48% from the prior year.
- Operating Leases retreated to $27.2 million in Q1 2026 per VYGR's latest filing, from $28.7 million in the prior quarter.
- Over five years, Operating Leases peaked at $42.0 million in Q1 2024 and troughed at $17.1 million in Q4 2023.
- A 5-year average of $28.5 million and a median of $28.7 million in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2024: Operating Leases tumbled 47.45% in 2022, then jumped 115.13% in 2024.
- Over 5 years, Operating Leases stood at $20.3 million in 2022, then dropped by 15.77% to $17.1 million in 2023, then jumped by 113.52% to $36.5 million in 2024, then slipped by 21.48% to $28.7 million in 2025, then decreased by 5.08% to $27.2 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $27.2 million, $28.7 million, and $30.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.69 Mn |
| Mar 31, 2026 | 27.20 Mn |
| Dec 31, 2025 | 28.66 Mn |
| Sep 30, 2025 | 30.52 Mn |
| Jun 30, 2025 | 32.57 Mn |
| Mar 31, 2025 | 34.57 Mn |
| Dec 31, 2024 | 36.50 Mn |
| Sep 30, 2024 | 38.37 Mn |
| Jun 30, 2024 | 40.21 Mn |
| Mar 31, 2024 | 42.00 Mn |
| Dec 31, 2023 | 17.09 Mn |
| Sep 30, 2023 | 17.92 Mn |
| Jun 30, 2023 | 18.73 Mn |
| Mar 31, 2023 | 19.52 Mn |
| Dec 31, 2022 | 20.29 Mn |
| Sep 30, 2022 | 21.02 Mn |
| Jun 30, 2022 | 21.74 Mn |
| Mar 31, 2022 | 37.12 Mn |
| Dec 31, 2021 | 38.61 Mn |
| Sep 30, 2021 | 40.01 Mn |